rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

ANAPTYSBIO, INC

10% owner

Company insider

Files Form 4 as: 10% owner, First Tracks Biotherapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
2
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
20 Apr 2026
Last trade
20 Apr 2026
Last filed
22 Apr 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
TRAX First Tracks Biotherapeutics10% owner · Biotechnology · last 20 Apr 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
20 Apr 2026filed 22 Apr 2026TRAX First Tracks BiotherapeuticsBiotechnologySEC FORM 4 Code J—100filing
20 Apr 2026filed 22 Apr 2026TRAX First Tracks BiotherapeuticsBiotechnologySEC FORM 4 Code J—100filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

John A. OrwinDirector · Director at First Tracks Biotherapeutics, filing Form 4 there in the last year
J. Anthony WareDirector · Director at First Tracks Biotherapeutics, filing Form 4 there in the last year
Benjamin StoneChief Business Officer · Chief Business Officer at First Tracks Biotherapeutics, filing Form 4 there in the last year
Daniel FagaPresident, CEO · President, CEO at First Tracks Biotherapeutics, filing Form 4 there in the last year
Paul F. LizzulChief Medical Officer · Chief Medical Officer at First Tracks Biotherapeutics, filing Form 4 there in the last year